Multimodality Therapy Including Proton Beam Therapy for AFP Producing Esophageal Cancer with Multiple Liver Metastases

被引:10
|
作者
Miyazaki, Tatsuya [1 ]
Sohda, Makoto [1 ]
Sakai, Makoto [1 ]
Kumakura, Yuji [1 ]
Yoshida, Tomonori [1 ]
Kuriyama, Kengo [1 ]
Yokobori, Takehiko [2 ]
Miyazaki, Masaya [3 ]
Hirato, Junko [4 ]
Okumura, Toshiyuki [5 ]
Ishikawa, Hitoshi [5 ]
Sakurai, Hideyuki [5 ]
Kuwano, Hiroyuki [1 ]
机构
[1] Gunma Univ, Grad Sch, Dept Gen Surg Sci, Maebashi, Gunma, Japan
[2] Gunma Univ, Grad Sch, Dept Mol Pharmacol & Oncol, Maebashi, Gunma, Japan
[3] Gunma Univ, Grad Sch, Dept Diagnost & Intervent Radiol, Maebashi, Gunma, Japan
[4] Gunma Univ, Grad Sch, Dept Pathol, Maebashi, Gunma, Japan
[5] Univ Tsukuba, Fac Med, Dept Radiat Oncol, Tsukuba, Ibaraki, Japan
基金
日本学术振兴会;
关键词
alpha-fetoprotein; Barrett's cancer; proton beam therapy; HEPATOID ADENOCARCINOMA; CONCURRENT CHEMOTHERAPY; TUBULAR ADENOCARCINOMA; BARRETTS-ESOPHAGUS; CHEMORADIOTHERAPY; CRYOABLATION; CARCINOMA; ALCOHOL; TRIAL;
D O I
10.2169/internalmedicine.0270-17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 50-year-old man who presented with a fever and epigastralgia was diagnosed to have esophageal carcinoma which was identified as poorly differentiated adenocarcinoma producing alpha-fetoprotein (AFP) with Barrett's esophagus. Computed tomography revealed multiple liver metastases and lymph node metastases surrounding the stomach. We first performed chemotherapy for the systemic lesions and proton beam therapy for the local control of lesions without complete remission and we were able to successfully control the frequently recurring lesions by proton beam therapy, cryotherapy and chemotherapy. A complete response has been maintained for 16 months and the overall survival time is 4 years and 2 months. Proton beam therapy for primary esophageal cancer and metastatic lesions was thus found to be an effective therapeutic option for such cases.
引用
收藏
页码:2333 / 2339
页数:7
相关论文
共 50 条
  • [21] Integration of surgery in multimodality therapy for esophageal cancer
    Ebie, N
    Kang, HJ
    Millikan, K
    Murthy, AK
    Griem, K
    Hartsell, W
    Recine, DC
    Doolas, A
    Taylor, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (01): : 11 - 15
  • [22] RESULTS OF SURGERY IN MULTIMODALITY THERAPY OF ESOPHAGEAL CANCER
    SCHLAG, P
    ONKOLOGIE, 1991, 14 (01): : 13 - &
  • [23] Multimodality Therapy for Esophageal Cancer: The Benefit of Chemoradiation
    Vossler, S. R.
    Bavan, B.
    Kunz, P.
    Ford, J. M.
    Fisher, G. A.
    Whyte, R.
    Koong, A. C.
    Chang, D. T.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S309 - S309
  • [24] Multimodality therapy for esophageal cancer: An emerging role
    Vokes, EE
    Mauer, AM
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1998, 4 (04): : 226 - 229
  • [25] Multimodality therapy for locally advanced esophageal cancer
    Paryani, Nitesh N.
    Ko, Stephen
    Hobbs, Corey James
    Kowalchik, Kristin
    Johnson, Elizabeth
    Kim, Siyong
    Vallow, Laura
    Peterson, Jennifer Layton
    Tzou, Katherine S.
    Buskirk, Steven J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [26] The role of multimodality therapy for resectable esophageal cancer
    Meneu-Diaz, JC
    Blazquez, LA
    Vicente, E
    Nuño, J
    Quijano, Y
    Lopez-Hervás, P
    Devesa, M
    Fresneda, V
    AMERICAN JOURNAL OF SURGERY, 2000, 179 (06): : 508 - 513
  • [27] Multimodality therapy of local regional esophageal cancer
    Kelsen, DP
    SEMINARS IN ONCOLOGY, 2005, 32 (06) : S6 - S10
  • [28] The potential of proton beam radiation therapy in lung cancer (including mesothelioma)
    Bjelkengren, G
    Glimelius, B
    ACTA ONCOLOGICA, 2005, 44 (08) : 881 - 883
  • [29] Proton therapy for patients with esophageal cancer: History, characteristics, clinical outcome and future direction of proton beam therapy
    Karube, Masataka
    Nakayama, Hidetsugu
    GLOBAL HEALTH & MEDICINE, 2021, 3 (03): : 149 - 156
  • [30] Clinical results of proton beam therapy for esophageal cancer at the University of Tsukuba
    Sugahara, S
    Tokuuye, K
    Nakahara, A
    Igaki, H
    Hata, M
    Kagei, K
    Terashima, H
    Hashimoto, T
    Fukumitsu, N
    Shibahara, T
    Ohara, K
    Akine, Y
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S163 - S164